# Oral Selenium Therapy for the Prevention of Mucositis

> **NCT01432873** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Tehran University of Medical Sciences** · enrollment: 76 (estimated)

## Conditions studied

- Mucositis
- Hematopoietic Stem Cell Transplantation

## Interventions

- **DRUG:** Oral selenium
- **DRUG:** Oral placebo

## Key facts

- **NCT ID:** NCT01432873
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-06
- **Primary completion:** 2012-10
- **Final completion:** 2012-12
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2012-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01432873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01432873, "Oral Selenium Therapy for the Prevention of Mucositis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01432873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*